undamentalytics Newsletter

Koski Thomas L: insider trades

Director at 2 companies we cover. 5 open-market purchases and 27 sales not made under a pre-set plan, reported from January 13, 2010 to June 20, 2019.

Would copying Koski Thomas L’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. After their sales, the shares moved +3.7% against the index over 12 months on average (a negative figure means selling was the right call); 52% trailed it. None of their purchases could be priced, so there is no copy portfolio.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Koski Thomas L: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 27 −1.3% +0.6% 48% 9 −1.72 0.12 No reliable evidence
Sales, 12 months after the report 27 +3.7% −2.6% 52% 9 −0.55 0.60 No reliable evidence
Sales, 12 months after the trade 27 +2.8% +1.6% 44% 9 −0.65 0.54 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Helios Technologies, Inc. HLIO —027March 24, 2010June 20, 2019
Oragenics Inc OGEN —50January 13, 2010September 18, 2018

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
June 20, 2019June 18, 2019 HLIO Sale $113,975 −9.3%−29.7%−30.5%
June 18, 2019June 17, 2019 HLIO Sale $1,180,724 −8.2%−28.2%−32.1%
June 17, 2019June 13, 2019 HLIO Sale $306,429 −7.4%−30.5%−29.6%
September 18, 2018September 14, 2018 OGEN Purchase $70,719 not yetnot yetnot yet
May 18, 2018May 16, 2018 HLIO Sale $1,230,000 −10.4%−21.4%−19.2%
March 8, 2016March 4, 2016 HLIO Sale $1,517,100 −17.9%−17.1%−13.4%
March 25, 2015March 23, 2015 HLIO Sale $911,240 −8.5%−18.8%−16.6%
March 2, 2015February 26, 2015 HLIO Sale $182,205 +0.9%−8.2%−20.6%
December 12, 2014December 10, 2014 OGEN Purchase $11,086 not yetnot yetnot yet
November 17, 2014November 13, 2014 OGEN Purchase $10,880 not yetnot yetnot yet
November 13, 2014November 12, 2014 OGEN Purchase $12,848 not yetnot yetnot yet
November 13, 2014November 10, 2014 HLIO Sale $401,355 −10.8%−29.2%−32.4%
March 10, 2014March 6, 2014 HLIO Sale $880,008 −11.1%−20.2%−25.4%
August 23, 2013August 21, 2013 HLIO Sale $368,762 +19.9%+4.5%+8.5%
June 14, 2013June 12, 2013 HLIO Sale $129,215 +6.7%+11.1%+5.3%
June 12, 2013June 10, 2013 HLIO Sale $214,858 +4.6%+5.3%+9.8%
May 24, 2013May 22, 2013 HLIO Sale $237,960 −3.1%−3.1%+0.5%
March 29, 2013March 27, 2013 HLIO Sale $1,130,755 −7.0%+12.3%+13.9%
March 15, 2013March 13, 2013 HLIO Sale $586,327 −11.1%+10.2%+9.2%
November 27, 2012November 23, 2012 HLIO Sale $94,107 +0.6%+38.6%+36.7%
August 20, 2012August 16, 2012 HLIO Sale $121,560 +4.6%+15.9%+14.7%
December 8, 2011December 6, 2011 HLIO Sale $246,300 +9.7%−7.4%−4.7%
July 5, 2011June 30, 2011 HLIO Sale $646,797 −17.6%−24.9%−27.6%
March 28, 2011March 24, 2011 HLIO Sale $885,547 +15.0%−12.1%−8.0%
March 14, 2011March 10, 2011 HLIO Sale $442,432 +9.0%−2.6%+1.6%
November 29, 2010November 24, 2010 HLIO Sale $896,689 +5.3%+6.1%+5.6%
November 24, 2010November 22, 2010 HLIO Sale $318,734 +1.7%+2.6%+7.9%
July 6, 2010July 2, 2010 HLIO Sale $549,175 +12.2%+84.9%+79.2%
June 24, 2010June 23, 2010 HLIO Sale $227,811 +5.0%+62.0%+61.2%
May 20, 2010May 18, 2010 HLIO Sale $303,985 −9.8%+53.5%+41.9%
March 24, 2010March 22, 2010 HLIO Sale $513,370 +2.8%+46.6%+40.3%
January 13, 2010January 11, 2010 OGEN Purchase $250,000 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Koski Thomas L traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.